|
| | Publication Year | Title | Author(s) |
| 21 | 10-Jun-2021 | Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution. | Lima, Luize G; Ham, Sunyoung; Shin, Hyunku; Chai, Edna P Z; Lek, Erica S H; Lobb, Richard J; Müller, Alexandra F; Mathivanan, Suresh; Yeo, Belinda ; Choi, Yeonho; Parker, Belinda S; Möller, Andreas |
| 22 | Jun-2021 | Neoadjuvant radiotherapy for locally advanced and high-risk breast cancer. | Chidley, Phoebe; Foroudi, Farshad ; Tacey, Mark A ; Khor, Richard ; Yeh, Janice; Bevington, Elaine; Hyett, Anthony; Loh, Su Wen; Chew, Grace ; McCracken, James; Neoh, Derek E ; Yeo, Belinda ; Baker, Caroline; Jassal, Sunil; Law, Michael; Zantuck, Natalie; Cokelek, Margaret; Guerrieri, Mario; Brown, Belinda; Stoney, David; Ng, Michael; Chao, Michael |
| 23 | 18-May-2021 | Uptake of bone modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry. | Wong, Vanessa ; de Boer, Richard; Dunn, Catherine; Anton, Angelyn; Malik, Laeeq; Greenberg, Sally; Yeo, Belinda ; Nott, Louise; Collins, Ian M; Torres, Javier; Barnett, Frances; Nottage, Michelle; Gibbs, Peter; Lok, Sheau Wen |
| 24 | 1-Jan-2021 | Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes. | Murphy, Alexandra C ; Koshy, Anoop N ; Cameron, William; Horrigan, Mark ; Kearney, Leighton; Yeo, Belinda ; Farouque, Omar ; Yudi, Matias B |
| 25 | Jan-2021 | CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care. | Hui, Rina; de Boer, Richard; Lim, Elgene; Yeo, Belinda ; Lynch, Jodi |
| 26 | 2021 | The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile. | Berthelet, Jean; Wimmer, Verena C; Whitfield, Holly J; Serrano, Antonin; Boudier, Thomas; Mangiola, Stefano; Merdas, Michal; El-Saafin, Farrah; Baloyan, David; Wilcox, Jordan; Wilcox, Steven; Parslow, Adam C; Papenfuss, Anthony T; Yeo, Belinda ; Ernst, Matthias ; Pal, Bhupinder; Anderson, Robin L ; Davis, Melissa J; Rogers, Kelly L; Hollande, Frédéric; Merino, Delphine |
| 27 | 2021 | Efficacy of mobile health cardiovascular risk-reduction strategies in cancer survivors. | Murphy, Alexandra C ; Koshy, Anoop N ; Mousley, Johanna; Meehan, Georgina; Kunniardy, Phelia ; Clark, David J ; Kearney, Leighton G ; Yeo, Belinda ; Farouque, Omar ; Yudi, Matias B |
| 28 | Dec-2020 | Breast ultrasound in breast cancer surveillance; incremental cancers found at what cost? | Bromley, Luke; Xu, Jennifer; Loh, Su-Wen; Chew, Grace ; Lau, Eddie ; Yeo, Belinda |
| 29 | Dec-2020 | Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer. | Conduit, C; de Boer, R H; Lok, S; Gibbs, P; Malik, L; Loh, Zoe ; Yeo, Belinda ; Greenberg, S; Devitt, B; Lombard, J; Nottage, M; Collins, I; Torres, J; Nolan, M; Nott, L |
| 30 | Nov-2020 | "First Do No Harm": Significance of Delays from Diagnosis to Surgery in Patients with Non-metastatic Breast Cancer. | Xu, Jennifer; Bromley, Luke; Chew, Grace ; Yeo, Belinda |
| 31 | Nov-2020 | Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer. | Kanjanapan, Yada; Lok, Sheau Wen; Gibbs, Peter; De Boer, Richard; Yeo, Belinda ; Greenberg, Sally; Barnett, Frances; Knott, Louise; Richardson, Gary; Wong, Rachel; Nottage, Michelle; Collins, Ian M; Torres, Javier; Lombard, Janine; Johns, Julie; Harold, Michael; Malik, Laeeq |
| 32 | Nov-2020 | Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer. | de Boer, Richard; Hui, Rina; Lim, Elgene; Yeo, Belinda ; Zdenkowski, Nicholas |
| 33 | Apr-2020 | Tracking Drug-Induced Epithelial-Mesenchymal Transition in Breast Cancer by a Microfluidic Surface-Enhanced Raman Spectroscopy Immunoassay. | Zhang, Zhen; Wang, Jing; Shanmugasundaram, Karthik Balaji; Yeo, Belinda ; Möller, Andreas; Wuethrich, Alain; Lin, Lynlee L; Trau, Matt |
| 34 | 23-Sep-2019 | Early enrichment of ESR1 mutations and the impact on gene expression in pre-surgical primary breast cancer treated with aromatase inhibitors. | Leal, Mariana F; Haynes, Benjamin P; Schuster, Eugene F; Yeo, Belinda ; Afentakis, Maria; Zabaglo, Lila; Martins, Vera; Buus, Richard; Dodson, Andrew; Cheang, Maggie C U; Smith, Ian E; Martin, Lesley-Ann; Dowsett, Mitch |
| 35 | 1-Jul-2019 | Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer. | Cheung, Yee-Ming Melody ; Ramchand, Sabashini K ; Yeo, Belinda ; Grossmann, Mathis |
| 36 | Mar-2019 | A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer. | Lok, Sheau W; Whittle, James R; Vaillant, François; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria João; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Bujak, Andjelija Zivanovic; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E; Lindeman, Geoffrey J |
| 37 | 2019 | Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations. | Lopez-Knowles, Elena; Pearson, Alex; Schuster, Gene; Gellert, Pascal; Ribas, Ricardo; Yeo, Belinda ; Cutts, Ros; Buus, Richard; Garcia-Murillas, Isaac; Haynes, Ben; Martin, Lesley-Ann; Smith, Ian; Turner, Nick; Dowsett, Mitch |
| 38 | 2019 | The effects of adjuvant endocrine therapy on bone health in women with breast cancer. | Ramchand, Sabashini K ; Cheung, Yee-Ming Melody ; Yeo, Belinda ; Grossmann, Mathis |
| 39 | 2019 | Ectopic breast cancer in the inguinal region. | Loh, Zoe ; Yeo, Belinda ; Williams, David S ; Gyorki, David E |
| 40 | 5-Dec-2018 | A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer. | Lindeman, Geoffrey J; Lok, Sheau Wen; Whittle, James R; Vaillant, Francois; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria J; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Zivanovic Bujak, Andjelija; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E |
Loading...
2
0
20
0
false
0000-0002-9218-9917